• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药房优选供应商组织。

Pharmacy preferred-provider organizations.

作者信息

Curtiss F R

出版信息

Am J Hosp Pharm. 1987 Aug;44(8):1797-801.

PMID:3631107
Abstract

The structure, features, and evolution of pharmacy preferred-provider organizations (PPOs) are described. Pharmacy PPOs may be sponsored by insurers, employers, providers, or independents (wherein the PPO functions as a third-party administrator); insurer and provider sponsorship are the most common. The advantages and disadvantages of these four types of sponsorship are described. Ways that pharmacy PPOs contain costs include the following: using drug product selection formularies (wherein providers are paid at prospective prices for generic products, regardless of the product dispensed or prescribed), reducing drug use by employing use-review mechanisms, and eliminating fraud and abuse through audits. Another cost-management feature being planned is the use of prescribing protocols. PPOs benefit pharmacies by increasing patronage and traffic flow, protecting market share, and improving cash flow by expediting payment of claims. Factors to consider in choosing a pharmacy PPO include the organization's market share, financial health, payment record, quality of claims processing, and long-term goals. As the pharmacy PPO industry matures, PPO financing will evolve from fee-for-service arrangements to moderate-risk contracting to full-risk contracting with plan buyers, using a negotiated amount per subscriber per month. Increasing competition and adoption of a credentialing process should result in more specific quality-of-care and performance standards for pharmacy PPOs.

摘要

本文描述了药学优选提供者组织(PPO)的结构、特点及发展情况。药学PPO可能由保险公司、雇主、提供者或独立机构发起(其中PPO充当第三方管理者);保险公司和提供者发起最为常见。文中阐述了这四种发起类型的优缺点。药学PPO控制成本的方式如下:使用药品选择处方集(其中不论配发或开出处方的产品如何,提供者按通用产品的预期价格获得报酬),通过采用使用审查机制减少用药,并通过审计消除欺诈和滥用行为。正在规划的另一项成本管理特点是使用开方协议。PPO通过增加光顾率和客流量、保护市场份额以及加快理赔支付改善现金流,从而使药房受益。选择药学PPO时需考虑的因素包括该组织的市场份额、财务状况、支付记录、理赔处理质量以及长期目标。随着药学PPO行业的成熟,PPO融资将从按服务收费安排演变为适度风险承包,再到与计划购买者进行全风险承包,采用每月每位订阅者的协商金额。竞争加剧和资格认证过程的采用应会为药学PPO带来更具体的护理质量和绩效标准。

相似文献

1
Pharmacy preferred-provider organizations.药房优选供应商组织。
Am J Hosp Pharm. 1987 Aug;44(8):1797-801.
2
Managed health care.管理式医疗保健
Am J Hosp Pharm. 1989 Apr;46(4):742-63.
3
Developing a PPO: challenges and benefits.
Health Prog. 1984 Dec;65(11):38-9, 54.
4
Preferred provider organizations. Implications of the fastest growing health care option.
Consultant. 1987 Apr;27(4):102-5.
5
Preferred provider organizations: options for Medicare.
Inquiry. 1989 Spring;26(1):24-34.
6
Questioning assumptions about preferred provider arrangements.质疑关于首选供应商安排的假设。
Inquiry. 1985 Summer;22(2):132-41.
7
The effects of sponsorship on PPO performance.
Health Cost Manage. 1988 Jul-Aug;5(4):15-22.
8
Preferred provider organizations: today's models and tomorrow's prospects.
Inquiry. 1986 Spring;23(1):7-15.
9
How can PPOs control prices without violating antitrust laws?
Hosp Prog. 1984 Mar;65(3):34-7.
10
Health-insurance products and plan options.健康保险产品及计划选项。
Am J Hosp Pharm. 1990 Oct;47(10):2265-9.